Ivan Bunganič

562 total citations
9 papers, 179 citations indexed

About

Ivan Bunganič is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Ivan Bunganič has authored 9 papers receiving a total of 179 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 3 papers in Surgery and 3 papers in Epidemiology. Recurrent topics in Ivan Bunganič's work include Inflammatory Bowel Disease (5 papers), Microscopic Colitis (3 papers) and Gastrointestinal disorders and treatments (2 papers). Ivan Bunganič is often cited by papers focused on Inflammatory Bowel Disease (5 papers), Microscopic Colitis (3 papers) and Gastrointestinal disorders and treatments (2 papers). Ivan Bunganič collaborates with scholars based in Hungary, Ukraine and Russia. Ivan Bunganič's co-authors include Roland Greinwald, Limas Kupčinskas, Karin Dilger, Ralph Müeller, Juris Pokrotnieks, Gediminas Kiudelis, Zsolt Tulassay, Zsolt Tulassay, E. А. Belousova and Volker Groß and has published in prestigious journals such as Gastroenterology, Neurogastroenterology & Motility and Journal of Crohn s and Colitis.

In The Last Decade

Ivan Bunganič

9 papers receiving 177 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivan Bunganič Hungary 6 109 95 71 42 18 9 179
Fabiana Castiglione Italy 6 96 0.9× 75 0.8× 91 1.3× 52 1.2× 17 0.9× 17 197
Marco Astegiano Italy 6 150 1.4× 124 1.3× 118 1.7× 33 0.8× 9 0.5× 10 246
Keith Friedenberg United States 5 108 1.0× 76 0.8× 62 0.9× 41 1.0× 13 0.7× 7 186
Laurent Peyrin-Biroulet France 7 102 0.9× 66 0.7× 41 0.6× 15 0.4× 4 0.2× 43 151
Kathleen O. Stewart United States 7 160 1.5× 135 1.4× 94 1.3× 33 0.8× 4 0.2× 14 242
Alexandros Skamnelos Greece 7 91 0.8× 67 0.7× 54 0.8× 24 0.6× 9 0.5× 16 154
Marijana Protić United States 8 160 1.5× 138 1.5× 56 0.8× 11 0.3× 11 0.6× 33 222
John P. Haydek United States 8 81 0.7× 81 0.9× 38 0.5× 24 0.6× 29 1.6× 20 217
Devinder Kumar United Kingdom 8 236 2.2× 152 1.6× 158 2.2× 40 1.0× 10 0.6× 16 312
Simeng Lin United Kingdom 8 63 0.6× 57 0.6× 50 0.7× 38 0.9× 2 0.1× 25 168

Countries citing papers authored by Ivan Bunganič

Since Specialization
Citations

This map shows the geographic impact of Ivan Bunganič's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Bunganič with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Bunganič more than expected).

Fields of papers citing papers by Ivan Bunganič

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Bunganič. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Bunganič. The network helps show where Ivan Bunganič may publish in the future.

Co-authorship network of co-authors of Ivan Bunganič

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Bunganič. A scholar is included among the top collaborators of Ivan Bunganič based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Bunganič. Ivan Bunganič is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Vermeire, Séverine, Bruce E. Sands, Herbert Tilg, et al.. (2022). ABX464 (obefazimod) for moderate-to-severe, active ulcerative colitis: a phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension. ˜The œLancet. Gastroenterology & hepatology. 7(11). 1024–1035. 41 indexed citations
2.
Kruis, Wolfgang, Tomas Poškus, G. Böhm, et al.. (2020). Rifamycin vs placebo for the treatment of acute uncomplicated diverticulitis: A randomised, double‐blind study. 2(6). 295–308. 5 indexed citations
3.
Tack, Jan, Juris Pokrotnieks, Gediminas Urbonas, et al.. (2018). Long‐term safety and efficacy of acotiamide in functional dyspepsia (postprandial distress syndrome)—results from the European phase 3 open‐label safety trial. Neurogastroenterology & Motility. 30(6). 33 indexed citations
4.
Dignaß, Axel, I Altorjay, Ivan Bunganič, et al.. (2014). Once versus three times daily dosing of oral budesonide for active Crohn's disease: A double-blind, double-dummy, randomised trial. Journal of Crohn s and Colitis. 8(9). 970–980. 29 indexed citations
5.
Kruis, Wolfgang, Thomas Eisenbach, H Löhr, et al.. (2013). 808 Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial of Mesalamine for the Prevention of Recurrence of Diverticulitis. Gastroenterology. 144(5). S–139. 11 indexed citations
6.
7.
Groß, Volker, Ivan Bunganič, E. А. Belousova, et al.. (2010). 3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: A double-blind, double-dummy, randomised trial. Journal of Crohn s and Colitis. 5(2). 129–138. 51 indexed citations
8.
9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabiana Castiglione Breakdown of academic impact, for papers by Marco Astegiano Breakdown of academic impact, for papers by Keith Friedenberg Breakdown of academic impact, for papers by Laurent Peyrin-Biroulet Breakdown of academic impact, for papers by Kathleen O. Stewart Breakdown of academic impact, for papers by Alexandros Skamnelos Breakdown of academic impact, for papers by Marijana Protić Breakdown of academic impact, for papers by John P. Haydek Breakdown of academic impact, for papers by Devinder Kumar Breakdown of academic impact, for papers by Simeng Lin
Rankless by CCL
2026